Use of the International Index of Erectile Function to assess sexual dysfunction in the male population with prostate cancer treated by radical prostatectomy – a systematic review
More details
Hide details
Doctoral School, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland
Department of Rehabilitation, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland
Department of Urology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
Submission date: 2021-04-07
Final revision date: 2021-05-04
Acceptance date: 2021-05-05
Online publication date: 2021-08-24
Corresponding author
Tomasz Jurys   

Grażyńskiego 46A/4, 40-126 Katowice, Poland. Tel.: +48 727 519 946.
Pol. Ann. Med. 2022;29(2):257-261
Prostate carcinoma is the second most commonly diagnosed cancer among men, accounting for 14.1% of diagnoses and with a 6.8% mortality rate. Among current treatment options, radical prostatectomy is strongly indicated for localized prostate cancer. Although surgical techniques for radical prostatectomy are constantly being improved in terms of effectiveness and safety, postoperative disorders such as stress urinary incontinence and sexual dysfunction, including erectile dysfunction, remain quite common.

The aim of our systematic review is to discuss the prevalence and severity of sexual dysfunction in the population of men suffering from prostate cancer who have been treated by means of radical prostatectomy.

Material and methods:
For the purposes of this systematic review we undertook a search of the literature in five databases using the English and Polish languages. We have focused on studies which assess sexual dysfunction using the International Index of Erectile Function (IIEF) questionnaire.

Results and discussion:
A total of 145 potentially relevant studies was retrieved. After selection, it was determined that 5 studies fulfilled the eligibility criteria and these were selected for qualitative synthesis. Our systematic review supports the finding that impairment of sexual function continues during the first 12 months after radical prostatectomy.

Sexual dysfunction is a common complication after radical prostatectomy, and recovery takes at least 12 months. The male population with prostate cancer is at risk of sexual dysfunction even before radical prostatectomy due to age, comorbidities and mental factors related to the course of the disease.

None declared.
None declared.
Wojciechowska U, Hurwitz LM, Helicki G, et al. Decade-long trends in prostate cancer incidence and mortality in Poland, 1999–2012. Pol Ann Med. 2018;25(1):56–61.
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3):209–249.
EAU, EANM, ESTRO, ESUR, ISUP, SIOG. Guidelines on Prostate Cancer. Published 2018. Updated 2021. Accessed March 26, 2021.
Albertsen PC. Observational studies and the natural history of screen-detected prostate cancer. Curr Opin Urol. 2015;25(3):232–237.
Wallis CJ, Herschorn S, Saskin R, et al. Complications after radical prostatectomy or radiotherapy for prostate cancer: results of a population-based, propensity score-matched analysis. Urology. 2015;85(3):621–627.
Park DL, Aron M, Rewcastle JC, Boyd SD, Gill IS. A model for managing erectile dysfunction following prostate cancer treatment. Curr Opin Urol. 2013;23(2):129–134.
Saleh A, Abboudi H, Ghazal-Aswad M, Mayer EK, Vale JA. Management of erectile dysfunction post-radical prostatectomy. Res Rep Urol. 2015;7:19–33.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–830.
Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54(2):346–351.
Koehler N, Holze S, Gansera L, et al. Erectile dysfunction after radical prostatectomy: the impact of nerve-sparing status and surgical approach. Int J Impot Res. 2012;24(4):155–160.
Acar C, Schoffelmeer CC, Tillier C, de Blok W, van Muilekom E, van der Poel HG. Quality of life in patients with low-risk prostate cancer. A comparative retrospective study: brachytherapy versus robot-assisted laparoscopic prostatectomy versus active surveillance. J Endourol. 2014;28(1):117–124.
van den Bergh RC, de Blok W, van Muilekom E, Tillier C, Venderbos LD, van der Poel HG. Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose?. Scand J Urol. 2014;48(4):367–373.
Geiger-Gritsch S, Oberaigner W, Mühlberger N, et al. Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck. Urol Int. 2015;94(4):419–427.
Yaxley JW, Coughlin GD, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet. 2016;388(10049):1057–1066.
DeLay KJ, Haney N, Hellstrom WJ. Modifying risk factors in the management of erectile dysfunction: A review. World J Mens Health. 2016;34(2):89–100.
Grover S, Shouan A. Assessment scales for sexual disorders – A review. J Psychosex Health. 2020;2(2):121–138.
Salonia A, Burnett AL, Graefen M, et al. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012;62(2):261–272.
Journals System - logo
Scroll to top